Figure 1From: Duloxetine in the treatment of Major Depressive Disorder: A comparison of efficacy in patients with and without melancholic featuresMean changes in HAMD17 Maier subscale for melancholic patients receiving duloxetine (60 mg QD) or placebo. ** p < .005 vs. placebo.Back to article page